Loading stock data...

Bacil Pharma Limited

BSE: BACPHAR

BSE
35.80 -1.88 (-4.99%)

Prev Close

37.68

Open Price

35.8

Volume

111

Today Low / High

35.8 / 35.8

52 WK Low / High

34.48 / 55.44

Range

34 - 38

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 35.8, reflecting a change of -1.88 (-4.98938%). The expected target range on the BSE is 34 - 38. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

30 Jun 35.80 0.00%
16 Jun 37.51 0.45%

Bacil Pharma Limited Graph

Bacil Pharma Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Bacil Pharma Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 35.80, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 35.80 36.16 32.54 - 39.77
36.52 29.21 - 43.82
36.87 25.81 - 47.94
Bearish Scenario 35.80 35.44 31.90 - 38.99
35.08 28.07 - 42.10
34.73 24.31 - 45.14

Overview of Bacil Pharma Limited

ISIN

INE711D01018

Industry

Medical - Pharmaceuticals

Vol.Avg

7,232

Market Cap

210,862,000

Last Dividend

0

Official Website

Visit Website

IPO Date

2000-01-03

DCF Diff

31.94

DCF

4

Financial Ratios Every Investor Needs

Stock Rating Details for BACPHAR

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 3 Neutral
ROE Score 3 Neutral
ROA Score 4 Buy
Debt-to-Equity (DE) Score 4 Buy
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr -0.25 Cr 0.40 Cr 0.58 0.41 Cr 0.0000
2024-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr -0.19 Cr -0.06 Cr -0.10 -0.06 Cr 0.0000
2023-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.01 Cr -0.18 Cr -0.10 Cr -0.17 -0.10 Cr 0.0000
2022-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.02 Cr -0.06 Cr -3.86 Cr -6.55 -3.86 Cr 0.0000
2021-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.01 Cr 0.01 Cr -0.17 Cr -0.24 Cr -0.41 -0.23 Cr 0.0000

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 2.86 Cr 25.60 Cr 0.17 Cr 25.4313 Cr 0.16 Cr -2.69 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 22.64 Cr 0.1689 Cr
2024-03-31 0.04 Cr 1.33 Cr 0.11 Cr 1.2132 Cr 0.10 Cr 0.06 Cr 0.00 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.1129 Cr
2023-03-31 0.03 Cr 1.13 Cr 0.03 Cr 1.0994 Cr 0.02 Cr -0.01 Cr 0.00 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.04 Cr 0.0279 Cr
2022-03-31 0.23 Cr 1.27 Cr 0.05 Cr 1.2244 Cr 0.03 Cr -0.20 Cr 0.00 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.16 Cr 0.0472 Cr
2021-03-31 0.10 Cr 4.09 Cr 2.70 Cr 1.3913 Cr 0.18 Cr 0.08 Cr 0.00 Cr 0.01 Cr 2.50 Cr 0.00 Cr 1.16 Cr 2.6970 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.4008 Cr 0.3367 Cr 2.0783 Cr 0.4008 Cr 2.8158 Cr 2.8573 Cr 0.0000 Cr 0.4076 Cr -0.6817 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 -0.0512 Cr 0.0489 Cr 0.0150 Cr -0.0513 Cr 0.0127 Cr 0.0415 Cr 0.0000 Cr -0.0590 Cr -0.0628 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 -0.1475 Cr -0.1163 Cr 0.0628 Cr -0.1475 Cr -0.2009 Cr 0.0288 Cr 0.0000 Cr -0.1019 Cr 0.0503 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 -4.0089 Cr 3.8122 Cr 0.3275 Cr -4.0089 Cr 0.1307 Cr 0.2298 Cr 0.0000 Cr -3.8600 Cr 0.3275 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 -0.3980 Cr 0.5278 Cr -0.0733 Cr -0.3980 Cr 0.0565 Cr 0.0990 Cr 0.0000 Cr -0.2392 Cr -0.0665 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.09 Cr 0.00 Cr 0.09 Cr 1.0000 0.05 Cr 0.02 Cr 0.02 0.02 Cr 0.1779
2024-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.06 Cr -0.06 Cr -0.10 -0.06 Cr 0.0000
2024-09-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.04 Cr 0.48 Cr 0.82 -0.07 Cr 0.0000
2024-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.04 Cr -0.03 Cr -0.06 -0.04 Cr 0.0000
2024-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.06 Cr -0.04 Cr -0.07 0.07 Cr 0.0000

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 2.86 Cr 0.00 Cr 2.86 Cr 0.00 Cr 0.00 Cr 2.91 Cr 0.00 Cr 25.60 Cr 0.17 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.12 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1.69 Cr
2024-09-30 0.12 Cr 0.00 Cr 0.12 Cr 0.00 Cr 0.00 Cr 0.15 Cr 0.00 Cr 1.86 Cr 0.17 Cr
2024-06-30 0.00 Cr 0.00 Cr 0.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1.21 Cr
2024-03-31 0.04 Cr 0.00 Cr 0.04 Cr 0.00 Cr 0.00 Cr 0.05 Cr 0.01 Cr 1.33 Cr 0.11 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 -0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.03 Cr 0.03 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹867.35 ₹103,816,443,451.00 ₹103,232.00

Key Executives

Manager
Mr. Ganpat Dhondu Salekar

Gender: male

Year Born: 1975

Company Secretary & Compliance Officer
Ms. Bhavana Tak

Gender: female

Year Born:

Executive Director
Mr. Prakash Bhoorchand Shah

Gender: male

Year Born: 1956

FAQs about Bacil Pharma Limited

Who is the CEO of the company?

The CEO is Ganpat Dhondu Salekar.

What is the current market price of the stock?

The current price is ₹35.80.

What is the 52-week price range?

The range is ₹34.48-55.44.

What is the market capitalization of the company?

The market capitalization is ₹21.09 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 69.10.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Bacil Pharma Limited (ISIN: INE711D01018) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹21.09 crores and an average daily volume of 7,232 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack